Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1122972

Cover Image

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1122972

Anticoagulants Market: Current Analysis and Forecast (2021-2027)

PUBLISHED:
PAGES: 189 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3999
PDF (Site License)
USD 5499
PDF (Global License)
USD 6999

Add to Cart

Global Anticoagulants Market is anticipated to grow with an elevated CAGR of around 7% over the forecast period (2021-2027). Anticoagulants are also called blood thinners and are used for treating and preventing blood clots which can block blood vessels. This blockage can occur in a vein or artery and can lead to serious complications such as heart attack or stroke as the clot disrupts the flow of blood to important organs. The anticoagulants market is expected to grow owing to the rising prevalence of various cardiovascular diseases coupled with a rapidly growing geriatric population. According to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The number of elderly is expected to double again by 2050 and reach nearly 2.1 billion worldwide. The occurrence of cardiovascular diseases is almost 15% higher in the elderly population as compared to the younger population. Owing to these glaring stats, there is a rising demand for blood thinners as it is one of the critical components for treating cardiovascular diseases. Furthermore, the increasing awareness and growing need for advanced & effective drugs are some other factors contributing to the growth of the market.

Johnson & Johnson, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Abbott Laboratories, Sanofi S.A., Pfizer, Inc., GlaxoSmithKline plc., Dr. Reddy's Laboratories, are some of the prominent players operating in the anticoagulants market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with anticoagulants.

Insights Presented in the Report

"Amongst Drug Class, novel oral anticoagulants segment holds the major share"

Based on the drug class, the anticoagulants market is segmented into novel oral anticoagulants (NOACs), heparin & low molecular weight heparin (LMWH), vitamin K antagonists, and others. The novel oral anticoagulants segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe. The segment is anticipated to grow on account of the growing adoption of NOACs in developing countries and the high preference for these drugs over warfarin. Some of the common NOACs are dabigatran, and rivaroxaban, among others.

"Amongst Application, pulmonary embolism segment holds the major share"

Based on application, the anticoagulants market is divided into pulmonary embolism, deep vein thrombosis, atrial fibrillation & heart attack, and others. The pulmonary embolism segment occupied the major share of the anticoagulants market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years owing to the growing prevalence of this disease and the availability of the most commercially successful anticoagulant, Eliquis, for this condition.

"Amongst Route of Administration, injectable segment holds the major share"

Based on the route of administration, the market is fragmented into oral and injectable. In 2020, the injectable segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The growth of this segment is because more patients prefer injectable anticoagulants currently. Some of the commonly used injectable anticoagulants are low molecular weight heparin, lepirudin, and danaparoid, among others. However, the oral segment is also expected to grow with a lucrative CAGR during the forecast period.

"North America represents one of the largest markets of Anticoagulants market"

For a better understanding of the market dynamics of the Anticoagulants market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the Anticoagulants market industry in 2020 owing to strong healthcare infrastructure and growing adoption of anticoagulants in the region.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The global anticoagulants market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Product Code: UMHE211074

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitations

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Anticoagulants Market
  • 2.2. Research Methodology of the Anticoagulants Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Anticoagulants Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL ANTICOAGULANTS MARKET COVID-19 IMPACT

6 GLOBAL ANTICOAGULANTS MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY DRUG CLASS

  • 7.1. Novel Oral Anticoagulants (NOACs)
  • 7.2. Heparin and Low Molecular Weight Heparin (LMWH)
  • 7.3. Vitamin K Antagonist
  • 7.4. Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Pulmonary Embolism
  • 8.2. Deep Vein Thrombosis (DVT)
  • 8.3. Atrial fibrillation & heart attack
  • 8.4. Others

9 MARKET INSIGHTS BY ROUTE OF ADMINISTRATION

  • 9.1. Oral
  • 9.2. Injectable

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Anticoagulants Market
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Anticoagulants Market
    • 10.2.1. Germany
    • 10.2.2. France
    • 10.2.3. United Kingdom
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia Pacific Anticoagulants Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. Rest of Asia Pacific
  • 10.4. Rest of World Anticoagulants Market

11 ANTICOAGULANTS MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 ANTICOAGULANTS MARKET OPPORTUNITIES

13 ANTICOAGULANTS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

  • 18.1. Johnson & Johnson
  • 18.2. Bayer AG
  • 18.3. Boehringer Ingelheim GmbH
  • 18.4. Bristol-Myers Squibb Company
  • 18.5. Daiichi Sankyo Company
  • 18.6. Abbott Laboratories
  • 18.7. Sanofi S.A.
  • 18.8. Pfizer, Inc.
  • 18.9. GlaxoSmithKline plc.
  • 18.10. Dr. Reddy's Laboratories

19 DISCLAIMER

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!